It’s a Merck product - I’ve got 800 shares. People will pay good money to get rid of their cancers.
The prices are usually knocked down by competition. When Gilead came out with the Hep C medication, they had a monopoly and wanted to charge $80K. Then Abbvie came out with one, and gave a deal for about $50K to big distributor. The next one that comes out will probably knock it to $30K.
My point being that gummint will pay...